Jade Biosciences, Inc.
JBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $76 | $596 | $717 | $288 |
| - Cash | $34 | $23 | $22 | $54 |
| + Debt | $0 | $1 | $1 | $1 |
| Enterprise Value | $42 | $573 | $696 | $234 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$69 | -$75 | -$51 | -$23 |
| % Margin | – | – | – | – |
| Net Income | -$70 | -$76 | -$52 | -$23 |
| % Margin | – | – | – | – |
| EPS Diluted | -85.262 | -100.382 | -73.671 | -32.956 |
| % Growth | 15.1% | -36.3% | -123.5% | – |
| Operating Cash Flow | -$71 | -$57 | -$39 | -$27 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$71 | -$57 | -$39 | -$28 |